3[1]Klun B. Spinal fluid and blood serum enzyme activity in brain injuries[J]. J Neurosurg,1974,41:224-224.
4[2]Bakay RAE. Enzymatic change in serum and cerebrospinal fluid in neurological injury[J]. J Neurosurg,1983,58:27-28.
5[2]Ruzak-Skocir B,Trbojevic-Cepe M.Study of serum and cerebrospinal fluid enzymes in diagnosis and differential diagnosis of cerebrovascular diseases.Neurologija,1990,39(4):239-50.
6[3]Parakh N,Gupta HL,Jain A.Evaluation of enzymes in serum and cerebrospinal fluid in cases of stroke.Neurol India,2002,50(4):518-519.
7[6]Olsson T,Marklund N,Gustafson Y,et al.Abnormalities at different levels of the hypothalamic-pituitary-adrenoc-ortical axis early after stroke.Stroke,1992,23(11):1573-1574.
8Y. Lampl,Diklah Geva,Ronit Gilad,Yehiel Eshel,L. Ronen,Ida Sarova-Pinhas. Cerebrospinal fluid magnesium level as a prognostic factor in ischaemic stroke[J] 1998,Journal of Neurology(9):584～588
9Scirica BM, Sabatine MS, Jarolim P, et al. Assessment of multiple cardiac Biomarkers in non-ST-segment elevation acute coronary syndromes : observa-Tions from the MERLIN-TIMI 36 trial [J]. Eur Heart J, 2011, 32(6): 69%705.
10Januzzi JL, Van KR Lainchbury J, et al. NT-proBNP testing for di-agnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study [J] Eur Heart J, 2006, 27 (3): 330-337.
